EMPAGLIFLOZIN for Prophylaxis: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 5 adverse event reports in the FDA FAERS database where EMPAGLIFLOZIN was used for Prophylaxis.
Most Reported Side Effects for EMPAGLIFLOZIN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Diabetic ketoacidosis | 3,644 | 9.8% | 85 | 2,610 |
| Fungal infection | 1,941 | 5.2% | 7 | 94 |
| Blood glucose increased | 1,797 | 4.9% | 4 | 306 |
| Euglycaemic diabetic ketoacidosis | 1,769 | 4.8% | 59 | 1,340 |
| Weight decreased | 1,661 | 4.5% | 25 | 328 |
| Urinary tract infection | 1,439 | 3.9% | 42 | 687 |
| Ketoacidosis | 1,411 | 3.8% | 57 | 969 |
| Dizziness | 1,372 | 3.7% | 13 | 274 |
| Nausea | 1,333 | 3.6% | 20 | 594 |
| Vomiting | 1,201 | 3.2% | 49 | 769 |
| Acute kidney injury | 1,023 | 2.8% | 72 | 751 |
| Fournier's gangrene | 1,000 | 2.7% | 63 | 681 |
| Diarrhoea | 999 | 2.7% | 19 | 314 |
| Dehydration | 973 | 2.6% | 24 | 581 |
| Pollakiuria | 944 | 2.6% | 6 | 90 |
Other Indications for EMPAGLIFLOZIN
Product used for unknown indication (16,449)
Type 2 diabetes mellitus (12,176)
Diabetes mellitus (4,267)
Cardiac failure (1,338)
Type 1 diabetes mellitus (383)
Chronic kidney disease (209)
Cardiac failure chronic (172)
Cardiac failure congestive (158)
Cardiac disorder (157)
Blood glucose increased (138)
Other Drugs Used for Prophylaxis
PEGFILGRASTIM (7,424)
HUMAN C1-ESTERASE INHIBITOR (5,950)
DENOSUMAB (4,541)
SULFAMETHOXAZOLE\TRIMETHOPRIM (3,197)
ASPIRIN (2,083)
VALACYCLOVIR (1,574)
PANTOPRAZOLE (1,502)
VARICELLA-ZOSTER VIRUS STRAIN OKA/MERCK LIVE ANTIGEN (1,444)
CLOPIDOGREL BISULFATE (1,296)
ENOXAPARIN (1,278)